Richard B. Rosse

3.8k total citations
123 papers, 2.9k citations indexed

About

Richard B. Rosse is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Richard B. Rosse has authored 123 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cellular and Molecular Neuroscience, 40 papers in Psychiatry and Mental health and 39 papers in Molecular Biology. Recurrent topics in Richard B. Rosse's work include Neuroscience and Neuropharmacology Research (32 papers), Schizophrenia research and treatment (24 papers) and Neurotransmitter Receptor Influence on Behavior (22 papers). Richard B. Rosse is often cited by papers focused on Neuroscience and Neuropharmacology Research (32 papers), Schizophrenia research and treatment (24 papers) and Neurotransmitter Receptor Influence on Behavior (22 papers). Richard B. Rosse collaborates with scholars based in United States and Australia. Richard B. Rosse's co-authors include Stephen I. Deutsch, Barbara L. Schwartz, John Mastropaolo, Maureen Fay-McCarthy, Tanya N. Alim, John M. Morihisa, Stephen I. Deutsch, Jessica A. Burket, Joseph Collins and Amy L. Drapalski and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Richard B. Rosse

121 papers receiving 2.7k citations

Peers

Richard B. Rosse
Mark E. Bardgett United States
W.E. Bunney United States
Josette G. Harris United States
Nicola G. Cascella United States
Göran C. Sedvall Sweden
Osamu Shirakawa Japan
George E. Jaskiw United States
Rajesh Narendran United States
Joseph I. Friedman United States
Nader D. Halim United States
Mark E. Bardgett United States
Richard B. Rosse
Citations per year, relative to Richard B. Rosse Richard B. Rosse (= 1×) peers Mark E. Bardgett

Countries citing papers authored by Richard B. Rosse

Since Specialization
Citations

This map shows the geographic impact of Richard B. Rosse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Rosse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Rosse more than expected).

Fields of papers citing papers by Richard B. Rosse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Rosse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Rosse. The network helps show where Richard B. Rosse may publish in the future.

Co-authorship network of co-authors of Richard B. Rosse

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Rosse. A scholar is included among the top collaborators of Richard B. Rosse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Rosse. Richard B. Rosse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deutsch, Stephen I., et al.. (2013). Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy. Schizophrenia Research. 148(1-3). 138–144. 54 indexed citations
2.
Deutsch, Stephen I., John Mastropaolo, Jessica A. Burket, & Richard B. Rosse. (2009). An epigenetic intervention interacts with genetic strain differences to modulate the stress-induced reduction of flurazepam's antiseizure efficacy in the mouse. European Neuropsychopharmacology. 19(6). 398–401. 9 indexed citations
3.
4.
5.
Deutsch, Stephen I., Richard B. Rosse, & Lynn H. Deutsch. (2006). Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer's disease. European Neuropsychopharmacology. 16(8). 547–551. 12 indexed citations
6.
Schwartz, Barbara L., et al.. (2006). Imitation of facial expressions in schizophrenia. Psychiatry Research. 145(2-3). 87–94. 32 indexed citations
7.
Mastropaolo, John, et al.. (2004). Behavioral consequences of methyllycaconitine in mice: a model of α7 nicotinic acetylcholine receptor deficiency. Life Sciences. 74(25). 3133–3139. 22 indexed citations
8.
Rosenberg, Paul B., et al.. (2002). Repetitive Transcranial Magnetic Stimulation Treatment of Comorbid Posttraumatic Stress Disorder and Major Depression. Journal of Neuropsychiatry. 14(3). 270–276. 96 indexed citations
9.
Deutsch, Stephen I., Richard B. Rosse, Eddie N. Billingslea, Alan S. Bellack, & John Mastropaolo. (2002). Topiramate antagonizes MK-801 in an animal model of schizophrenia. European Journal of Pharmacology. 449(1-2). 121–125. 39 indexed citations
10.
Rosenberg, Paul B., Richard B. Rosse, Barbara L. Schwartz, & Stephen I. Deutsch. (2000). Nefazodone in the Adjunctive Therapy of Schizophrenia: An Open-Label Exploratory Study. Clinical Neuropharmacology. 23(4). 222–225. 6 indexed citations
11.
Rosse, Richard B., et al.. (1998). Visual scanning of faces correlates with schizophrenia symptomatology. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 22(6). 971–979. 15 indexed citations
12.
Ollo, Christine, et al.. (1996). Lack of Neurotoxic Effect of Diethylpropion in Crack-Cocaine Abusers. Clinical Neuropharmacology. 19(1). 52–58. 6 indexed citations
13.
Rosenberg, Paul B., Richard B. Rosse, Maureen Fay-McCarthy, et al.. (1996). Smooth Pursuit Eye Movements in the Evaluation of Famotidine Adjunctive Therapy of Schizophrenia: A Preliminary Report. Clinical Neuropharmacology. 19(3). 276–281. 1 indexed citations
14.
Alim, Tanya N., et al.. (1995). Diethylpropion Pharmacotherapeutic Adjuvant Therapy for Inpatient Treatment of Cocaine Dependence. Clinical Neuropharmacology. 18(2). 183–195. 21 indexed citations
15.
Rosse, Richard B., et al.. (1992). Clock drawing in the screening assessment of cognitive impairment in an ambulatory care setting: A preliminary report. General Hospital Psychiatry. 14(2). 142–144. 45 indexed citations
16.
Rosse, Richard B., Anil K. Malhotra, Sun Young Kim, & Stephen I. Deutsch. (1992). Visual fixation deficits and evidence of cognitive impairment in schizophrenia. Biological Psychiatry. 31(4). 412–414. 14 indexed citations
17.
Rosse, Richard B., et al.. (1991). Substance Use Diagnoses and Discharge Patterns Among Psychiatric Inpatients. Psychiatric Services. 42(4). 403–405. 24 indexed citations
18.
Rosse, Richard B., et al.. (1991). Subtype diagnosis in schizophrenia and its relation to neuropsychological and computerized tomography measures. Biological Psychiatry. 30(1). 63–72. 26 indexed citations
19.
Rosse, Richard B.. (1990). Depot testosterone attenuates the anticonvulsant effect of flurazepam in mice. Psychoneuroendocrinology. 15(1). 83–85. 13 indexed citations
20.
Deutsch, Stephen I., et al.. (1989). The Role of Excitatory Amino Acids and Intraneuronal Calcium in the Acute Intoxicational Effects of Ethanol. Clinical Neuropharmacology. 12(6). 483–489. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark E. Bardgett Breakdown of academic impact, for papers by W.E. Bunney Breakdown of academic impact, for papers by Josette G. Harris Breakdown of academic impact, for papers by Nicola G. Cascella Breakdown of academic impact, for papers by Göran C. Sedvall Breakdown of academic impact, for papers by Osamu Shirakawa Breakdown of academic impact, for papers by George E. Jaskiw Breakdown of academic impact, for papers by Rajesh Narendran Breakdown of academic impact, for papers by Joseph I. Friedman Breakdown of academic impact, for papers by Nader D. Halim
Rankless by CCL
2026